Biocon Earnings
- All
- News
- Videos
-
Biocon's March Quarter Profit Falls 4% To Rs 283 Crore
Biocon Ltd on Thursday reported a 4 per cent decline in consolidated net profit to Rs 283.9 crore in the fourth quarter ended on March 31, 2022
-
Biocon Declines Over 3% After Net Profit Increased 105% In March Quarter
Biocon Share Price Today: On Friday, Biocon opened on the BSE at Rs 392, touching an intra day high of Rs 392 and an intra day low of Rs 380.55, in the trading session so far.
-
Biocon Net Profit Jumps 105% To Rs 254 Crore In March Quarter
Biocon Q4 Results: Biocon's consolidated revenue increased 26 per cent in the fourth quarter of the fiscal 2020-21 to Rs 2,044 crore, compared to Rs 1,621 crore in the corresponding quarter last year.
-
Stocks To Watch: TCS, Tata Power, Biocon, Bharat Rasayan, ONGC
The S&P BSE Sensex and NSE Nifty 50 indexes are set to open higher in trade on Friday as indicated by the Nifty futures traded on Singapore Exchange
-
Derivatives Expiry, Quarterly Results To Guide Market Trend: Experts
Companies such as Larsen & Toubro, TVS Motor Company, Hindustan Unilever, Zee Entertainment Enterprises, IDFC First Bank, Ambuja Cements, Bank of Baroda, Biocon, Mphasis, Tata Motors, ABB India, Bajaj Auto, Maruti Suzuki India, ICICI Bank are expected to announce their Q1 earning results in the coming week
-
Biocon Posts Rs 217 Crore Profit In December Quarter, Beats Analysts' Estimates
Profit rose to Rs 217 crore in the third quarter ended December 31, compared with a profit of Rs 91.9 crore a year earlier, the company said.
-
Biocon Reports 355 Crore Rupees Consolidated Net Profit For Q2
Net profit grew whopping on account of strong top line, including biosimilar Pegfilgrastim sales in the US and margin expansion.
-
Biocon Reports 47% Jump In June Quarter Profit, Beats Analysts' Estimates
Biocon reported a net profit of Rs 120 crore for the quarter ended June 30, as against Rs 81.3 crore for the corresponding quarter a year ago.
-
Biocon Shares Fall 7% As Q1 Profit Slumps
Biocon shares opened the day on a disappointing note and further declined 6.86 per cent to Rs 371.70 on the Bombay Stock Exchange (BSE).
-
How Kiran Shaw Shut Up Her Twitter Trolls With Pharma Stock Rally
Biocon chief say the drop in twitter trolls has less to do with her outreach than the almost 80 percent rally in Biocon shares.
-
Biocon Hits 52-Week High On Strong Q2 Earnings
Excluding exceptional item, Biocon had posted a net profit of Rs 97 crore in September quarter of the previous year.
-
Biocon Posts Profit Of Rs 147 Crore In Q2
The company had posted a net loss of Rs 10.6 crore for the corresponding period of the previous fiscal year, it said in a filing to the BSE.
-
Sensex Rises 145 Points Led By ICICI Bank, Nifty Settles Near 8,700
From the Nifty basket of shares, 25 were declining while 26 were advancing.
-
Biocon Hits Fresh 52-Week High On Strong Q1 Performance
Biocon's EBITDA or operating profit jumped 26 per cent to Rs 263 crore compared to Rs 208 crore last fiscal.
-
Biocon Posts 17% Rise In Q1 Profit
Biotechnology major Biocon on Thursday posted a 17 per cent rise in net profit at Rs 147 crore for the fiscal first quarter that ended on June 30, 2016, on the back of robust growth in segments like biologics and branded formulations.
-
Biocon's March Quarter Profit Falls 4% To Rs 283 Crore
Biocon Ltd on Thursday reported a 4 per cent decline in consolidated net profit to Rs 283.9 crore in the fourth quarter ended on March 31, 2022
-
Biocon Declines Over 3% After Net Profit Increased 105% In March Quarter
Biocon Share Price Today: On Friday, Biocon opened on the BSE at Rs 392, touching an intra day high of Rs 392 and an intra day low of Rs 380.55, in the trading session so far.
-
Biocon Net Profit Jumps 105% To Rs 254 Crore In March Quarter
Biocon Q4 Results: Biocon's consolidated revenue increased 26 per cent in the fourth quarter of the fiscal 2020-21 to Rs 2,044 crore, compared to Rs 1,621 crore in the corresponding quarter last year.
-
Stocks To Watch: TCS, Tata Power, Biocon, Bharat Rasayan, ONGC
The S&P BSE Sensex and NSE Nifty 50 indexes are set to open higher in trade on Friday as indicated by the Nifty futures traded on Singapore Exchange
-
Derivatives Expiry, Quarterly Results To Guide Market Trend: Experts
Companies such as Larsen & Toubro, TVS Motor Company, Hindustan Unilever, Zee Entertainment Enterprises, IDFC First Bank, Ambuja Cements, Bank of Baroda, Biocon, Mphasis, Tata Motors, ABB India, Bajaj Auto, Maruti Suzuki India, ICICI Bank are expected to announce their Q1 earning results in the coming week
-
Biocon Posts Rs 217 Crore Profit In December Quarter, Beats Analysts' Estimates
Profit rose to Rs 217 crore in the third quarter ended December 31, compared with a profit of Rs 91.9 crore a year earlier, the company said.
-
Biocon Reports 355 Crore Rupees Consolidated Net Profit For Q2
Net profit grew whopping on account of strong top line, including biosimilar Pegfilgrastim sales in the US and margin expansion.
-
Biocon Reports 47% Jump In June Quarter Profit, Beats Analysts' Estimates
Biocon reported a net profit of Rs 120 crore for the quarter ended June 30, as against Rs 81.3 crore for the corresponding quarter a year ago.
-
Biocon Shares Fall 7% As Q1 Profit Slumps
Biocon shares opened the day on a disappointing note and further declined 6.86 per cent to Rs 371.70 on the Bombay Stock Exchange (BSE).
-
How Kiran Shaw Shut Up Her Twitter Trolls With Pharma Stock Rally
Biocon chief say the drop in twitter trolls has less to do with her outreach than the almost 80 percent rally in Biocon shares.
-
Biocon Hits 52-Week High On Strong Q2 Earnings
Excluding exceptional item, Biocon had posted a net profit of Rs 97 crore in September quarter of the previous year.
-
Biocon Posts Profit Of Rs 147 Crore In Q2
The company had posted a net loss of Rs 10.6 crore for the corresponding period of the previous fiscal year, it said in a filing to the BSE.
-
Sensex Rises 145 Points Led By ICICI Bank, Nifty Settles Near 8,700
From the Nifty basket of shares, 25 were declining while 26 were advancing.
-
Biocon Hits Fresh 52-Week High On Strong Q1 Performance
Biocon's EBITDA or operating profit jumped 26 per cent to Rs 263 crore compared to Rs 208 crore last fiscal.
-
Biocon Posts 17% Rise In Q1 Profit
Biotechnology major Biocon on Thursday posted a 17 per cent rise in net profit at Rs 147 crore for the fiscal first quarter that ended on June 30, 2016, on the back of robust growth in segments like biologics and branded formulations.
